Living with COPD and its psychological effects on participating in community-based physical activity in Brazil: a qualitative study. Findings from the Breathe Well group.


Journal

NPJ primary care respiratory medicine
ISSN: 2055-1010
Titre abrégé: NPJ Prim Care Respir Med
Pays: England
ID NLM: 101631999

Informations de publication

Date de publication:
25 Oct 2024
Historique:
received: 23 10 2023
accepted: 13 09 2024
medline: 26 10 2024
pubmed: 26 10 2024
entrez: 25 10 2024
Statut: epublish

Résumé

Physical activity (PA) improves dyspnoea, psychological wellbeing and quality of life (QoL) for people with COPD reducing their risk of exacerbation. However, engagement in PA is low especially amongst those with anxiety and depression, and PA programmes are limited in countries with limited resources such as Brazil. We explored perceptions of 21 people with COPD about the impact of their disease on taking part in community-based PA programmes in Sao Paulo, Brazil through semi-structured telephone interviews from October 2020 to April 2021. Discussions were audio-recorded, transcribed, and analysed using the Framework method. Five themes were identified: Knowledge about COPD and its management; Self-perception of life with COPD; Knowledge and experiences of depression and anxiety; Opinions on PA and repercussions of COVID-19. PA was considered to be important in bringing physical and mental health benefits but there were barriers in accessibility of formal PR programmes and therefore local community PA programmes were considered to be important. People with mental health conditions tended to view PA more negatively. COVID-19 had reduced PA opportunities, access to COPD treatment and social interaction, and was associated with more exacerbations and emotional suffering. In general, this study showed an urgent need to improve knowledge about COPD and its risk factors and management among both patients, the public and primary healthcare professionals. We provide important content for the formulation of public policies for the implementation of specific activity programmes for people with COPD in community spaces using local resources and intersectoral partnerships.

Identifiants

pubmed: 39455598
doi: 10.1038/s41533-024-00386-7
pii: 10.1038/s41533-024-00386-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

33

Informations de copyright

© 2024. The Author(s).

Références

GBD 2016 Brazil Collaborators. Burden of disease in Brazil, 1990-2016: a systematic subnational analysis for the Global Burden of Disease Study 2016. Lancet 392, 760–775 (2018).
doi: 10.1016/S0140-6736(18)31221-2
Rabahi, M. Epidemiology of COPD: facing challenges. Pulmão RJ 22, 4–8 (2013).
Christenson, S. A., Smith, B. M., Bafadhel, M. & Putcha, N. Chronic obstructive pulmonary disease. Lancet 399, 2227–2242 (2022).
pubmed: 35533707 doi: 10.1016/S0140-6736(22)00470-6
Miravitlles, M. & Ribera, A. Understanding the impact of symptoms on the burden of COPD. Respir. Res. 18, 67 (2017).
pubmed: 28431503 pmcid: 5399825 doi: 10.1186/s12931-017-0548-3
O’Donnell, D. E., Milne, K. M., James, M. D., de Torres, J. P. & Neder, J. A. Dyspnea in COPD: new mechanistic insights and management implications. Adv. Ther. 37, 41–60 (2020).
pubmed: 31673990 doi: 10.1007/s12325-019-01128-9
Machado, A. et al. Burtin C. Impact of acute exacerbations of COPD on patients’ health status beyond pulmonary function: a scoping review. Pulmonology 14, S2531–0437 (2022).
Putcha, N., Drummond, M. B., Wise, R. A. & Hansel, N. N. Comorbidities and chronic obstructive pulmonary disease: prevalence, influence on outcomes, and management. Semin. Respir. Crit. Care Med. 36, 575–591 (2015).
pubmed: 26238643 pmcid: 5004772 doi: 10.1055/s-0035-1556063
Laforest, L. et al. Frequency of comorbidities in chronic obstructive pulmonary disease, and impact on all-cause mortality: a population-based cohort study. Respir. Med. 117, 33–39 (2016).
pubmed: 27492511 doi: 10.1016/j.rmed.2016.05.019
Garvey, C. & Criner, G. J. Impact of comorbidities on the treatment of chronic obstructive pulmonary disease. Am. J. Med. 131, 23–29 (2018).
pubmed: 29777661 doi: 10.1016/j.amjmed.2018.05.002
Kiani, F. Z. & Ahmadi, A. Prevalence of different comorbidities in chronic obstructive pulmonary disease among Shahrekord PERSIAN cohort study in southwest Iran. Sci. Rep. 11, 1548 (2021).
pubmed: 33452286 pmcid: 7810834 doi: 10.1038/s41598-020-79707-y
Santos, N. C. D. et al. Prevalence and impact of comorbidities in individuals with chronic obstructive pulmonary disease: a systematic review. Tuberc. Respir. Dis. 85, 205–220 (2022).
doi: 10.4046/trd.2021.0179
Yohannes, A. M., Kaplan, A. & Hanania, N. A. COPD in primary care: key considerations for optimized management: anxiety and depression in chronic obstructive pulmonary disease: recognition and management. J. Fam. Pract. 67, S11–S18 (2018).
pubmed: 29443332
Lima, C. A. et al. Quality of life, anxiety and depression in patients with chronic obstructive pulmonary disease. Rev. Bras Enferm. 73, e20190423 (2020).
pubmed: 32667477 doi: 10.1590/0034-7167-2019-0423
YIN, H. L. et al. Prevalence of comorbidities in chronic obstructive pulmonary disease patients: a meta-analysis. Medicine 96, e6836 (2017).
pubmed: 28489768 pmcid: 5428602 doi: 10.1097/MD.0000000000006836
Pumar, M. I. et al. Anxiety and depression-Important psychological comorbidities of COPD. J. Thorac. Dis. 6, 1615–1631 (2014).
pubmed: 25478202 pmcid: 4255157
Wang, J., Willis, K., Barson, E. & Smallwood, N. The complexity of mental health care for people with COPD: a qualitative study of clinicians’ perspectives. NPJ Prim. Care Respir. Med. 31, 40 (2021).
pubmed: 34294727 pmcid: 8298614 doi: 10.1038/s41533-021-00252-w
Martínez-Gestoso, S. et al. Impact of anxiety and depression on the prognosis of copd exacerbations. BMC Pulm. Med. 22, 169 (2022).
pubmed: 35488330 doi: 10.1186/s12890-022-01934-y
Hernandes, N. A. et al. Profile of the level of physical activity in the daily lives of patients with COPD in Brazil. J. Bras Pneumol. 35, 949–956 (2009).
pubmed: 19918626 doi: 10.1590/S1806-37132009001000002
Pitta, F. et al. Comparison of daily physical activity between People with COPD from Central Europe and South America. Respir. Med. 103, 421–426 (2009).
pubmed: 19006659 doi: 10.1016/j.rmed.2008.09.019
Shin, K. C. Physical activity in chronic obstructive pulmonary disease: clinical impact and risk factors. Korean J. Intern. Med. 33, 75–77 (2018).
pubmed: 29334725 doi: 10.3904/kjim.2017.387
Nyssen, S. M. et al. Levels of physical activity and predictors of mortality in COPD. J. Bras Pneumol. 39, 659–666 (2013).
pubmed: 24473759 pmcid: 4075906 doi: 10.1590/S1806-37132013000600004
Taylor, G. M. et al. Smoking cessation for improving mental health. Cochrane Database Syst. Rev. 3, CD013522 (2021).
pubmed: 33687070
Action on Smoking and Health [ASH], Royal College of Psychiatrists, Public Mental Health Implementation Centre. Public mental health and smoking. A framework for action. https://ash.org.uk/uploads/Public-mental-health-and-smoking.pdf?v=1659737441 (2022).
Gimeno-Santos, E. et al. Determinants and outcomes of physical activity in patients with COPD: a systematic review. Thorax 69, 731–739 (2014).
pubmed: 24558112 doi: 10.1136/thoraxjnl-2013-204763
Dueñas-Espín, I. et al. Depression symptoms reduce physical activity in People with COPD: a prospective multicenter study. Int. J. Chron. Obstruct. Pulmon. Dis. 11, 1287–1295 (2016).
pubmed: 27354787 pmcid: 4910613 doi: 10.2147/COPD.S101459
Xiang, X., Huang, L., Fang, Y., Cai, S. & Zhang, M. Physical activity and chronic obstructive pulmonary disease: a scoping review. BMC Pulm. Med. 22, 301 (2022).
pubmed: 35932050 pmcid: 9354440 doi: 10.1186/s12890-022-02099-4
Machado, A., Oliveira, A., Valente, C., Burtin, C. & Marques, A. Effects of a community-based pulmonary rehabilitation programme during acute exacerbations of chronic obstructive pulmonary disease - A quasi-experimental pilot study. Pulmonology 26, 27–38 (2020).
pubmed: 31164288 doi: 10.1016/j.pulmoe.2019.05.004
Spruit, M. A., Pitta, F., McAuley, E., ZuWallack, R. L. & Nici, L. Pulmonary rehabilitation and physical activity in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 192, 924–933 (2015).
pubmed: 26161676 doi: 10.1164/rccm.201505-0929CI
Strawbridge, W. J., Deleger, S., Roberts, R. E. & Kaplan, G. A. Physical activity reduces the risk of subsequent depression for older adults. Am. J. Epidemiol. 156, 328–334 (2002).
pubmed: 12181102 doi: 10.1093/aje/kwf047
Kaczynski, A. T., Manskem, S. R., Mannellm, R. C. & Grewal, K. Smoking and physical activity: a systematic review. Am. J. Health Behav. 32, 93–110 (2008).
pubmed: 18021037 doi: 10.5993/AJHB.32.1.9
Meshe, O. F., Claydon, L. S., Bungay, H. & Andrew, S. The relationship between physical activity and health status in patients with chronic obstructive pulmonary disease following pulmonary rehabilitation. Disabil. Rehabil. 39, 746–756 (2017).
pubmed: 27049603 doi: 10.3109/09638288.2016.1161842
Marques, A. et al. Improving access to community-based pulmonary rehabilitation: 3R protocol for real-world settings with cost-benefit analysis. BMC Public Health 19, 676 (2019).
pubmed: 31151409 pmcid: 6544941 doi: 10.1186/s12889-019-7045-1
Barbosa, M., Andrade, R., de Melo, C. A. & Torres, R. Community-based pulmonary rehabilitation programs in individuals with COPD. Respir. Care 67, 579–593 (2022).
pubmed: 35473839 doi: 10.4187/respcare.09627
Neves, L. F., Reis, M. H. & Gonçalves, T. R. Home or community-based pulmonary rehabilitation for individuals with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Cad. Saude Publica 32, e00085915 (2016).
doi: 10.1590/0102-311X00085915
D’Avila, O. P. et al. Use of health services and family health strategy households population coverage in Brazil. Cienc Saude Colet 26, 3955–3964 (2021).
doi: 10.1590/1413-81232021269.11782021
Martins, S. M. et al. Accuracy and economic evaluation of screening tests for undiagnosed COPD among hypertensive individuals in Brazil. NPJ Prim Care Respir. Med. 32, 55 (2022).
pubmed: 36513683 pmcid: 9747958 doi: 10.1038/s41533-022-00303-w
Robinson, R. S. Purposive Sampling. in Encyclopedia of Quality of Life and Well-Being Research (eds Michalos, A. C.) (Springer, 2014).
Kovelis, D. et al. Validation of the Modified Pulmonary Functional Status and Dyspnea Questionnaire and the Medical Research Council scale for use in Brazilian patients with chronic obstructive pulmonary disease. J. Bras Pneumol. 34, 1008–1018 (2008).
pubmed: 19180335 doi: 10.1590/S1806-37132008001200005
Silva, G. P. F., Morano, M. T. A. P., Viana, C. M. S., Magalhaes, C. B. A. & Pereira, E. D. B. Portuguese-language version of the COPD assessment test: validation for use in Brazil. J. Bras Pneumol. 39, 402–408 (2013).
pubmed: 24068260 pmcid: 4075870 doi: 10.1590/S1806-37132013000400002
Santos, I. S. et al. Sensitivity and specificity of the Patient Health Questionnaire-9 (PHQ-9) among adults from the general population. Cad Saude Publica 29, 1533–1543 (2013).
pubmed: 24005919 doi: 10.1590/S0102-311X2013001200006
Bergerot, C. D., Laros, J. A. & Araujo, T. C. C. F. Avaliação de ansiedade e depressão em pacientes oncológicos: comparação psicométrica. Psico-USF 19, 187–197 (2014).
doi: 10.1590/1413-82712014019002004
Spitzer, R. L., Kroenke, K., Williams, J. B. & Löwe, B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch. Intern. Med. 166, 1092–1097 (2006).
pubmed: 16717171 doi: 10.1001/archinte.166.10.1092
Jordan, P., Shedden-Mora, M. C. & Löwe, B. Psychometric analysis of the Generalized Anxiety Disorder scale (GAD-7) in primary care using modern item response theory. PLoS ONE 12, e0182162 (2017).
pubmed: 28771530 pmcid: 5542568 doi: 10.1371/journal.pone.0182162
São-João, T. M. et al. Cultural adaptation of the Brazilian version of the Godin-Shephard Leisure-Time Physical Activity questionnaire. Rev. Saude Publica 47, 479–487 (2013).
pubmed: 24346560 doi: 10.1590/S0034-8910.2013047003947
Amireault, S., Godin, G., Lacombe, J. & Sabiston, C. M. The use of the Godin-Shephard Leisure-Time Physical Activity Questionnaire in oncology research: a systematic review. BMC Med. Res. Methodol. 15, 60 (2015).
pubmed: 26264621 pmcid: 4542103 doi: 10.1186/s12874-015-0045-7
Gouveia, V. V., Lima, T. J. S., Gouveia, R. S. V., Freires, L. A. & Barbosa, L. H. G. M. General Health Questionnaire (GHQ-12): the effect of negative items in its factorial structure. Cad Saude Publica 28, 375–384 (2012).
pubmed: 22331163 doi: 10.1590/S0102-311X2012000200016
Anjara, S. G., Bonetto, C., Van Bortel, T. & Brayne, C. Using the GHQ-12 to screen for mental health problems among primary care patients: psychometrics and practical considerations. Int. J. Ment. Health Syst. 14, 1–13 (2020).
doi: 10.1186/s13033-020-00397-0
Moises, C. Jr Online data collection as adaptation in conducting quantitative and qualitative research during the COVID-19 pandemic. Eur. J. Educ. Stud. 7, 79–89 (2020).
Baillie, L. Promoting and evaluating scientific rigour in qualitative research. Nurs. Stand. 29, 36–42 (2015).
pubmed: 26174283 doi: 10.7748/ns.29.46.36.e8830
Johnson, J. L., Adkins, D. & Chauvin, S. A review of the quality indicators of Rigor in Qualitative Research. Am. J. Pharm. Educ. 84, 7120 (2020).
pubmed: 32292186 pmcid: 7055404 doi: 10.5688/ajpe7120
Smith, J. & Firth, J. Qualitative data analysis: the framework approach. Nurs. Res. 18, 52–62 (2011).
doi: 10.7748/nr2011.01.18.2.52.c8284
Gale, N. K., Heath, G., Cameron, E., Rashid, S. & Redwood, S. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med. Res. Methodol 13, 117 (2013).
pubmed: 24047204 pmcid: 3848812 doi: 10.1186/1471-2288-13-117
de Queiroz, M. C. et al. Knowledge about COPD among users of primary health care services. Int. J. Chron. Obstruct Pulmon. Dis. 10, 1–6 (2015).
pubmed: 25565794
Adeloye, D. et al. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir. Med. 10, 447–458 (2022).
pubmed: 35279265 pmcid: 9050565 doi: 10.1016/S2213-2600(21)00511-7
Yang, H. et al. Disease knowledge and self-management behavior of People with COPD in China. Medicine 98, e14460 (2019).
pubmed: 30813148 pmcid: 6408037 doi: 10.1097/MD.0000000000014460
Enocson, A. et al. Case-finding for COPD in primary care: a qualitative study of patients’ perspectives. Int. J. Chron. Obstruct Pulmon. Dis. 13, 1623–1632 (2018).
pubmed: 29844668 pmcid: 5963478 doi: 10.2147/COPD.S147718
Vachon, B. et al. Challenges and Strategies for Improving COPD Primary Care Services in Quebec: Results of the Experience of the COMPAS+ Quality Improvement Collaborative. Int. J. Chron. Obstruct Pulmon. Dis. 17, 259–272 (2022).
pubmed: 35140460 pmcid: 8819163 doi: 10.2147/COPD.S341905
Kharbanda, S. & Anand, R. Health-related quality of life in patients with chronic obstructive pulmonary disease: a hospital-based study. Indian J. Med. Res. 153, 459–464 (2021).
pubmed: 34380792 pmcid: 8354058 doi: 10.4103/ijmr.IJMR_1812_18
Von Leupoldt, A. Treating anxious expectations can improve dyspnoea in patients with COPD. Eur. Respir. J. 50, 1701352 (2017).
Spathis, A. et al. Cutting through complexity: the Breathing, Thinking, Functioning clinical model is an educational tool that facilitates chronic breathlessness management. NPJ Prim. Care Respir. Med. 31, 25 (2021).
pubmed: 33972569 pmcid: 8110567 doi: 10.1038/s41533-021-00237-9
Tiemensma, J., Gaab, E., Voorhaar, M., Asijee, G. & Kaptein, A. A. Illness perceptions and coping determine quality of life in People with COPD. Int. J. Chron. Obstruct. Pulmon. Dis. 11, 2001–2007 (2016).
pubmed: 27601893 pmcid: 5003510 doi: 10.2147/COPD.S109227
Jarab, A., Alefishat, E., Mukattash, T., Alzoubi, K. & Pinto, S. Patients’ perspective of the impact of COPD on quality of life: a focus group study for patients with COPD. Int. J. Clin. Pharm. 40, 573–579 (2018).
pubmed: 29542033 doi: 10.1007/s11096-018-0614-z
Zarghami, M., Taghizadeh, F., Sharifpour, A. & Alipour, A. Efficacy of smoking cessation on stress, anxiety, and depression in smokers with chronic obstructive pulmonary disease: a randomized controlled clinical trial. Addict. Health 10, 137 (2018).
pubmed: 31105911 pmcid: 6511395
Kosteli, M.-C. et al. Barriers and enablers of physical activity engagement for patients with COPD in primary care. Int. J. Chron. Obstruct. Pulmon. Dis. 12, 1019–1031 (2017).
pubmed: 28405162 pmcid: 5378459 doi: 10.2147/COPD.S119806
Robinson, H., Williams, V., Curtis, F., Bridle, C. & Jones, A. W. Facilitators and barriers to physical activity following pulmonary rehabilitation in COPD: a systematic review of qualitative studies. NPJ Prim. Care Respir. Med. 28, 19 (2018).
pubmed: 29867117 pmcid: 5986863 doi: 10.1038/s41533-018-0085-7
Dogra, S. et al. Physical activity and sedentary time are related to clinically relevant health outcomes among adults with obstructive lung disease. BMC Pulm. Med. 18, 98 (2018).
pubmed: 29879930 pmcid: 5992845 doi: 10.1186/s12890-018-0659-8
Instituto Brasileiro de Geografia e Estatística (IBGE). Censo 2022-Panorama https://censo2022.ibge.gov.br/panorama/ (2022).
Instituto Brasileiro de Geografia e Estatística (IBGE). Sinopse do Censo Demográfico 2010 https://www.ibge.gov.br/censo2010/apps/sinopse/index.php?dados=P9&uf=00 (2011).
Hume, E. et al. Impact of COVID-19 shielding on physical activity and quality of life in patients with COPD. Breathe 16, 200231 (2020).
pubmed: 33447283 pmcid: 7792782 doi: 10.1183/20734735.0231-2020
Yohannes, A. M. People with COPD in a COVID-19 society: depression and anxiety. Expert Rev. Respir. Med. 15, 5–7 (2021).
pubmed: 32578464 doi: 10.1080/17476348.2020.1787835

Auteurs

S M Martins (SM)

Center for Public Health Studies (CESCO) at the University Center of the ABC Medical School, São Paulo, Brazil.

R Adams (R)

Health Services Management Centre, School of Social Policy and Society, University of Birmingham, Birmingham, UK. r.l.adams@bham.ac.uk.

E M Rodrigues (EM)

Center for Public Health Studies (CESCO) at the University Center of the ABC Medical School, São Paulo, Brazil.

R Stelmach (R)

Respiratory Division, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.

P Adab (P)

Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.

C Chi (C)

Department of General Practice, Peking University First Hospital, Beijing, China.

K K Cheng (KK)

Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.

B G Cooper (BG)

Lung Function & Sleep, Queen Elizabeth Hospital, Birmingham, UK.

J Correia-de-Sousa (J)

International Primary Care Respiratory Group, Larbert, Scotland.
Life and Health Sciences Research Institute (ICVS), School of Medicine, PT Government Associate Laboratory, ICVS/3B's, University of Minho, Braga/Guimarães, Portugal.

A P Dickens (AP)

Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.
Observational and Pragmatic Research Institute, Midview City, Singapore.

A Enocson (A)

Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.

A Farley (A)

Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.

N Gale (N)

Health Services Management Centre, School of Social Policy and Society, University of Birmingham, Birmingham, UK.

K Jolly (K)

Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.

R E Jordan (RE)

Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.

S Jowett (S)

Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.

M Maglakelidze (M)

Petre Shotadze Tbilisi Medical Academy, Tbilisi, Georgia.

T Maghlakelidze (T)

Ivane Javakhishvili Tbilisi State University, Tbilisi, Georgia.

A Sitch (A)

Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.
National Institute for Health and Care Research (NIHR), Birmingham Biomedical Research Centre, Birmingham, UK.

K Stavrikj (K)

Center for Family Medicine, Faculty of Medicine, Ss.Cyril and Methodius University in Skopje, Skopje, Republic of North Macedonia.

A M Turner (AM)

Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.

S Williams (S)

International Primary Care Respiratory Group, Larbert, Scotland.

V B Nascimento (VB)

Center for Public Health Studies (CESCO) at the University Center of the ABC Medical School, São Paulo, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH